Yatin Suneja analyst GUGGENHEIM

Currently out of the existing stock ratings of Yatin Suneja, 134 are a BUY (83.75%), 26 are a HOLD (16.25%).

Yatin Suneja

Work Performance Price Targets & Ratings Chart

Analyst Yatin Suneja, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 41.18% that have a potential upside of 33.21% achieved within 184 days.

Yatin Suneja’s has documented 368 price targets and ratings displayed on 41 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 01-Nov-2024.

Wall Street Analyst Yatin Suneja

Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for IMVT (IMMUNOVANT ) at 9/22/2023. The price target of $32 was fulfilled within 4 days with a profit of $11.61 (56.94%) receiving and performance score of 142.35.

Average potential price target upside

ACAD ACADIA Pharmaceuticals ALXN Alexion Pharmaceuticals ARGX argenx NV ADR BIIB Biogen BTAI BioXcel Therapeutics CELG Celgene GBT Global Blood Therapeutics GWPH GW Pharmaceuticals plc IFRX InflaRx N.V. LJPC La Jolla Pharmaceutical Co ORPH Orphazyme A/S PHAT Phathom Pharmaceuticals SAGE Sage Therapeutic XENE Xenon Pharmaceuticals ZGNX Zogenix REGN Regeneron Pharmaceuticals SGEN Seagen AGIO Agios Pharm ANAB AnaptysBio ELYM Eliem Therapeutics AXSM Axsome Therapeutics CLDX Celldex Therapeutics EYPT Eyepoint Pharmaceuticals SRZN Surrozen BLCO Bausch + Lomb Corp HZNP Horizon Pharma PLC RXDX Prometheus Biosciences KRTX Karuna Therapeutics IMVT Immunovant  LBPH Longboard Pharmaceuticals LRMR Larimar Therapeutics RAPT RAPT Therapeutics RLMD Relmada Therapeutics VIGL Vigil Neuroscience VRNA Verona Pharma PLC ADR CABA Cabaletta Bio MLTX MoonLake Immunotherapeutics RETA Reata Pharmaceuticals ROIV Roivant Sciences Ltd SEEL Seelos Therapeutics NBIX Neurocrine Biosciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$27

$10.58 (64.43%)

$27

13 days ago
(07-Nov-2024)

8/22 (36.36%)

$9.79 (56.89%)

119

Buy

$28

$11.58 (70.52%)

$28

13 days ago
(07-Nov-2024)

0/4 (0%)

$10.79 (62.70%)

Hold

1 months 10 days ago
(10-Oct-2024)

11/14 (78.57%)

$9.98 (39.89%)

141

Buy

$23

$6.58 (40.07%)

$30

3 months 12 days ago
(08-Aug-2024)

0/3 (0%)

$7.28 (46.31%)

Buy

$20

$3.58 (21.80%)

$28

3 months 13 days ago
(07-Aug-2024)

16/21 (76.19%)

$4.83 (31.84%)

184

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Yatin Suneja is most bullish on?

Potential upside of $542.11 has been obtained for REGN (REGENERON PHARMACEUTICALS)

Which stock is Yatin Suneja is most reserved on?

Potential downside of $12.81 has been obtained for VIGL (VIGIL NEUROSCIENCE)

What Year was the first public recommendation made by Yatin Suneja?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?